SHOOK DAVID (Chief Medical Officer) received a stock award from LYELL IMMUNOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/11/2025ACC: 0001415889-25-016728
Officer· Chief Medical Officer
Since Feb 2026
+65.65K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
65.65K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.90K
Price / share
—
Trade value
—
% of position
New position
6/9/2025
0.00→21.90K
Total
Net shares
+21.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2025 | A · Award | +21.90K | — | — | New position | 0.00 | 21.90K |
| Total | +21.90K | $0.00 | ||||||
Derivative Transactions1
Option (right to buy)
Direct
Converts to
Common Stock
43.75K shares
Shares
+43.75K
Strike price
12.47
Held after
43.75K
Exercisable
—
6/9/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Common Stock43.75K shares | 6/9/2025 | A · Award | +43.75K | 12.47 | — | 43.75K |